PEGASUS TIMI54

Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin

Stadium
klaar
Middel
ticagrelor
Populatie
ASCVD
Fase
III
First Patient In
15 november 2010
Last Patient In
-
Last Patient Last Visit
-

Studiedirecteur

dr. G.L. Bartels

Cardioloog

De pagina is verlopen.